ArticleJournal of cardiac failure2025
Outcomes After Heart Transplantation Among Non-Native English-Speaking Recipients.
Article in Journal of cardiac failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Primary Language, Social Determinants of Health, and the Lived Patient Experience After Heart Transplantation: A Comparative Qualitative Study.Clinical transplantation · 2026Article
- Not Lost in Translation: Learning From the Non-native English-Speaking Heart Transplant Recipient Experience.Journal of cardiac failure · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
introductionEffective communication and understanding are imperative for heart transplant (HT) recipients who require lifelong adherence to treatment plans and medications. Whether non-native English speaking (NNES) recipients have inferior outcomes compared to native English-speaking recipients (NES) has not been studied post-HT.
methodsWe reviewed adult HT recipients at Columbia University Irving Medical Center from January 2005-December 2022; primary language was determined by chart review. Baseline characteristics and patient-level zip codes, which were used to derive the socioeconomic status (SES) index by using data from the Agency for Healthcare Research and Quality (AHRQ), were included. Mortality at 1 year and 5 years was compared between NNES and NES recipients. Survival curves were estimated using the Kaplan-Meier method, and log-rank testing was used to compare survival between groups. Secondary outcomes, including all-cause hospitalization, hospitalization for infection and rejection at 1 year, as well as rejection and cardiac allograft vasculopathy at 5 years, were analyzed using cumulative incidence functions with Gray testing to detect differences between groups. Multivariable Cox proportional hazard models were used to determine whether there was an association between NNES and primary and secondary outcomes.
resultsOf 1066 HT recipients, 103 (10%) were NNES. NNES recipients were more likely to identify as non-White, to have Medicaid as the primary payer and to have lower educational attainment. On average, NNES recipients resided in zip codes with higher levels of unemployment and lower household incomes. Overall, NNES had lower median AHRQ SES indices (51 vs 55; P < 0.001). After adjustment for clinical factors, including socioeconomic status, race/ethnicity and education level, mortality at 1 and 5 years for NNES and NES recipients were not significantly different, although there was a trend toward improved survival rates in the NNES group (1-year adjusted hazard ratio (HR) 0.24, 95% CI 0.06-1.01; P = 0.05; 5-year adjusted HR 0.48, 95% CI 0.22-1.03; P = 0.06). Similarly, there were no differences in need for rehospitalization, infection requiring hospitalization or rejection at 1 year.
conclusionsThere were no significant differences in outcomes at 1 year and 5 years post-HT between NNES and NES. Availability of interpreter services and educational resources in multiple languages are paramount to maintaining effective communication and equitable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.